News

Sg2 recommends health systems focus on short-term care redesign and long-term investment plans for catheterization labs, care teams, resources and patient beds to match forecasted demand. The paper includes multiple short- and long-term...

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

Data show patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra’s computer assisted vacuum thrombectomy (CAVT™) technology have a shorter length of hospital stay, shorter post-procedure length of stay, and fewer...

“We have already seen its effectiveness in multiple models of atherosclerosis,” said Andrei Maiseyeu, associate professor at the Cardiovascular Research Institute and Department of Biomedical Engineering at Case Western Reserve’s School of...

"Existing low-energy defibrillation protocols yield only a moderate reduction in tissue damage and pain," author Roman Grigoriev said. "Our study shows these can be completely eliminated. Conventional protocols require substantial power for...

"Older adults, especially those with heart disease, are at greater risk due to the strain that hot temperatures put on the heart. Understanding the impacts of different cooling strategies on the heart is important to help vulnerable people...

In a recent study, over 90% of the participants had their infection cleared, and they had lower in-hospital mortality compared to those whose infections remained.

The International Space Station research project will examine microgravity’s effect on heart tissue and is designed to better understand how microgravity affects the function of the human heart.

The different design is thought to increase back pressure, redistributing blood flow more fully through small vessels in the heart that were not working at capacity.

DISRUPT BTK II's primary effectiveness endpoint of procedural success, defined as ≤50% residual stenosis for all treated target lesions without serious angiographic complications, was met with a rate of 97.9% at 30 days.